Diessenbacher P - Search Results

1

Up-regulation of the T cell quiescence factor KLF2 in a leukaemic T-cell line after expression of the inositol 5'-phosphatase SHIP-1.

García-Palma L, Horn S, Haag F, Diessenbacher P, Streichert T, Mayr GW, Jücker M. García-Palma L, et al. Among authors: diessenbacher p. Br J Haematol. 2005 Dec;131(5):628-31. doi: 10.1111/j.1365-2141.2005.05811.x. Br J Haematol. 2005. PMID: 16351639 Free article.

2

T-cell survival regulator LKLF is not involved in inappropriate apoptosis of diabetes-prone BBDP rat T cells.

Diessenbacher P, Bartels K, Koch-Nolte F, Haag F. Diessenbacher P, et al. Ann N Y Acad Sci. 2003 Dec;1010:548-51. doi: 10.1196/annals.1299.101. Ann N Y Acad Sci. 2003. PMID: 15033788

3

Probing the expression and function of the P2X7 purinoceptor with antibodies raised by genetic immunization.

Adriouch S, Dubberke G, Diessenbacher P, Rassendren F, Seman M, Haag F, Koch-Nolte F. Adriouch S, et al. Among authors: diessenbacher p. Cell Immunol. 2005 Jul-Aug;236(1-2):72-7. doi: 10.1016/j.cellimm.2005.08.011. Epub 2005 Sep 12. Cell Immunol. 2005. PMID: 16165114

4

Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.

Geserick P, Drewniok C, Hupe M, Haas TL, Diessenbacher P, Sprick MR, Schön MP, Henkler F, Gollnick H, Walczak H, Leverkus M. Geserick P, et al. Among authors: diessenbacher p. Oncogene. 2008 May 15;27(22):3211-20. doi: 10.1038/sj.onc.1210985. Epub 2007 Dec 17. Oncogene. 2008. PMID: 18084329

5

NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.

Diessenbacher P, Hupe M, Sprick MR, Kerstan A, Geserick P, Haas TL, Wachter T, Neumann M, Walczak H, Silke J, Leverkus M. Diessenbacher P, et al. J Invest Dermatol. 2008 May;128(5):1134-47. doi: 10.1038/sj.jid.5701141. Epub 2007 Nov 8. J Invest Dermatol. 2008. PMID: 17989734 Free article.

6

Autocrine TNF is critical for the survival of human dendritic cells by regulating BAK, BCL-2, and FLIPL.

Lehner M, Kellert B, Proff J, Schmid MA, Diessenbacher P, Ensser A, Dörrie J, Schaft N, Leverkus M, Kämpgen E, Holter W. Lehner M, et al. Among authors: diessenbacher p. J Immunol. 2012 May 15;188(10):4810-8. doi: 10.4049/jimmunol.1101610. Epub 2012 Apr 13. J Immunol. 2012. PMID: 22504646

7

FLIP ing the coin? Death receptor-mediated signals during skin tumorigenesis.

Leverkus M, Diessenbacher P, Geserick P. Leverkus M, et al. Among authors: diessenbacher p. Exp Dermatol. 2008 Jul;17(7):614-22. doi: 10.1111/j.1600-0625.2008.00728.x. Exp Dermatol. 2008. PMID: 18558995

8

Premonitory epidermolysis bullosa acquisita mimicking eyelid dermatitis: successful treatment with rituximab and protein A immunoapheresis.

Kubisch I, Diessenbacher P, Schmidt E, Gollnick H, Leverkus M. Kubisch I, et al. Among authors: diessenbacher p. Am J Clin Dermatol. 2010;11(4):289-93. doi: 10.2165/11533210-000000000-00000. Am J Clin Dermatol. 2010. PMID: 20373827

9

Systemic allergic contact dermatitis from intravenous piritramide.

Waltermann K, Geier J, Diessenbacher P, Schadendorf D, Hillen U. Waltermann K, et al. Among authors: diessenbacher p. Allergy. 2010 Sep;65(9):1203-4. doi: 10.1111/j.1398-9995.2010.02331.x. Epub 2010 Feb 26. Allergy. 2010. PMID: 20192944 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters